Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort

生物标志物 队列 载脂蛋白E 内科学 前瞻性队列研究 肿瘤科 医学 胶质纤维酸性蛋白 心理学 胃肠病学 纵向研究 病理 内分泌学 疾病 化学 免疫组织化学 生物化学
作者
Pratishtha Chatterjee,Steve Pedrini,James D. Doecke,Rohith N. Thota,Victor L. Villemagne,Vincent Doré,Abhay K. Singh,Penghao Wang,Stephanie R. Rainey‐Smith,Christopher Fowler,Kevin Taddei,Hamid R. Sohrabi,Mark P. Molloy,David Ames,Paul Maruff,Christopher C. Rowe,Colin L. Masters,Ralph N. Martins
出处
期刊:Alzheimers & Dementia [Wiley]
卷期号:19 (4): 1117-1134 被引量:146
标识
DOI:10.1002/alz.12724
摘要

Plasma amyloid beta (Aβ)1-42/Aβ1-40 ratio, phosphorylated-tau181 (p-tau181), glial fibrillary acidic protein (GFAP), and neurofilament light (NfL) are putative blood biomarkers for Alzheimer's disease (AD). However, head-to-head cross-sectional and longitudinal comparisons of the aforementioned biomarkers across the AD continuum are lacking.Plasma Aβ1-42, Aβ1-40, p-tau181, GFAP, and NfL were measured utilizing the Single Molecule Array (Simoa) platform and compared cross-sectionally across the AD continuum, wherein Aβ-PET (positron emission tomography)-negative cognitively unimpaired (CU Aβ-, n = 81) and mild cognitive impairment (MCI Aβ-, n = 26) participants were compared with Aβ-PET-positive participants across the AD continuum (CU Aβ+, n = 39; MCI Aβ+, n = 33; AD Aβ+, n = 46) from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL) cohort. Longitudinal plasma biomarker changes were also assessed in MCI (n = 27) and AD (n = 29) participants compared with CU (n = 120) participants. In addition, associations between baseline plasma biomarker levels and prospective cognitive decline and Aβ-PET load were assessed over a 7 to 10-year duration.Lower plasma Aβ1-42/Aβ1-40 ratio and elevated p-tau181 and GFAP were observed in CU Aβ+, MCI Aβ+, and AD Aβ+, whereas elevated plasma NfL was observed in MCI Aβ+ and AD Aβ+, compared with CU Aβ- and MCI Aβ-. Among the aforementioned plasma biomarkers, for models with and without AD risk factors (age, sex, and apolipoprotein E (APOE) ε4 carrier status), p-tau181 performed equivalent to or better than other biomarkers in predicting a brain Aβ-/+ status across the AD continuum. However, for models with and without the AD risk factors, a biomarker panel of Aβ1-42/Aβ1-40, p-tau181, and GFAP performed equivalent to or better than any of the biomarkers alone in predicting brain Aβ-/+ status across the AD continuum. Longitudinally, plasma Aβ1-42/Aβ1-40, p-tau181, and GFAP were altered in MCI compared with CU, and plasma GFAP and NfL were altered in AD compared with CU. In addition, lower plasma Aβ1-42/Aβ1-40 and higher p-tau181, GFAP, and NfL were associated with prospective cognitive decline and lower plasma Aβ1-42/Aβ1-40, and higher p-tau181 and GFAP were associated with increased Aβ-PET load prospectively.These findings suggest that plasma biomarkers are altered cross-sectionally and longitudinally, along the AD continuum, and are prospectively associated with cognitive decline and brain Aβ-PET load. In addition, although p-tau181 performed equivalent to or better than other biomarkers in predicting an Aβ-/+ status across the AD continuum, a panel of biomarkers may have superior Aβ-/+ status predictive capability across the AD continuum.Area under the curve (AUC) of p-tau181 ≥ AUC of Aβ42/40, GFAP, NfL in predicting PET Aβ-/+ status (Aβ-/+). AUC of Aβ42/40+p-tau181+GFAP panel ≥ AUC of Aβ42/40/p-tau181/GFAP/NfL for Aβ-/+. Longitudinally, Aβ42/40, p-tau181, and GFAP were altered in MCI versus CU. Longitudinally, GFAP and NfL were altered in AD versus CU. Aβ42/40, p-tau181, GFAP, and NfL are associated with prospective cognitive decline. Aβ42/40, p-tau181, and GFAP are associated with increased PET Aβ load prospectively.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
隐形曼青应助我大哥爱吃采纳,获得10
1秒前
糖豆子发布了新的文献求助20
3秒前
澡雪发布了新的文献求助10
3秒前
之之发布了新的文献求助10
4秒前
4秒前
5秒前
林泳慧发布了新的文献求助10
5秒前
5秒前
XZY完成签到,获得积分10
6秒前
身斜不怕尹子正完成签到,获得积分10
7秒前
wangmin发布了新的文献求助10
9秒前
yuanyuan发布了新的文献求助30
9秒前
ice完成签到,获得积分20
9秒前
林泳慧完成签到,获得积分10
10秒前
小王关注了科研通微信公众号
11秒前
科目三应助梦醒时见你采纳,获得10
11秒前
ice发布了新的文献求助10
12秒前
汉堡包应助孙成成采纳,获得10
12秒前
niu完成签到,获得积分10
12秒前
rumengren完成签到 ,获得积分10
13秒前
14秒前
16秒前
顾矜应助yuanyuan采纳,获得10
16秒前
sbw完成签到,获得积分10
17秒前
17秒前
17秒前
18秒前
18秒前
18秒前
18秒前
18秒前
18秒前
18秒前
涛浪完成签到,获得积分10
19秒前
小手凉凉发布了新的文献求助10
19秒前
berry完成签到,获得积分10
20秒前
量子星尘发布了新的文献求助10
20秒前
张广安发布了新的文献求助10
22秒前
23秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975610
求助须知:如何正确求助?哪些是违规求助? 3519986
关于积分的说明 11200337
捐赠科研通 3256337
什么是DOI,文献DOI怎么找? 1798246
邀请新用户注册赠送积分活动 877446
科研通“疑难数据库(出版商)”最低求助积分说明 806357